O‐glycan biosynthesis in human colorectal adenoma cells during progression to cancer

European Journal of Biochemistry

Volumn 222, Issue 2, 1994, Pages 415-424

  VAVASSEUR, Fabienne ^a   DOLE, Kiran ^a   YANG, Jimmy ^a   MATTA, Khushi L ^b   MYERSCOUGH, Neil ^c   CORFIELD, Anthony ^c   PARASKEVA, Christos ^d   BROCKHAUSEN, Inka ^a,e  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c BRISTOL ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; GLYCOSYLTRANSFERASE; MUCIN; SIALYLTRANSFERASE; TN ANTIGEN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADENOMA; ARTICLE; BIOSYNTHESIS; CARCINOGENESIS; CELL LINE; COLON ADENOMA; COLON POLYPOSIS; CONTROLLED STUDY; FUCOSYLATION; HUMAN; HUMAN CELL; PRECANCER; PRIORITY JOURNAL; SIALYLATION;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; AMINO ACID SEQUENCE; ANTIBODIES; ANTIBODY SPECIFICITY; CARBOHYDRATE SEQUENCE; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; GLYCOPROTEINS; GLYCOSYLTRANSFERASES; HUMAN; MOLECULAR SEQUENCE DATA; MUCINS; NEOPLASM PROTEINS; POLYSACCHARIDES; PRECANCEROUS CONDITIONS; SUBSTRATE SPECIFICITY; SULFOTRANSFERASES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0028235332     PISSN: 00142956     EISSN: 14321033     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1994.tb18880.x     Document Type: Article

References (54)

1. Clinical aspects of glycoprotein synthesis
2. x antigen as defined by monoclonal antibody AM‐3 is a marker of dysplasia in the colonic adeno‐carcinoma sequence
3. y blood group‐related antigens in human malignant, premalignant, and nonmalignant colonic tissues
4. x antigens in human colorectal polyps
5. A cancer‐associated mucin alteration in benign colonic polyps
6. Mucin associated Tn and sialosyl‐Tn antigen expression in colorectal polyps
7. Cancer‐associated alterations of blood group antigen expression in human colorectal polyps
8. Hyperplastic polyps of the colon and rectum
9. Alterations of membrane glycopeptides in human colonic adenocarcinoma
10. Analysis of cancer‐associated colonic mucin by ionexchange chromatography: evidence for a mucin species of lower molecular charge and weight in cancer
11. The carbohydrate composition of mucin in colonic cancer
12. Mucin changes in ileoanal pouches monitored by metabolic labelling and histochemistry
13. Structure and biology of carcinoma‐associated mucin MUC1
14. Neoplastic transformation of a human colonic epithelial cell line: experimental evidence for the adenoma to carcinoma sequence
15. A single human colonic adenoma cell line can be converted in vitro to both a colorectal adenocarcinoma and a mucinous carcinoma
16. Characterization of a sialic acid‐rich mucus glycoprotein secreted by a premalignant human colorectal adenoma cell line
17. Loss of sialic acid O‐acetylation in human colorectal cancer cells
18. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis
19. Mucin oligosaccharide biosynthesis in human colonic cancerous tissues and cell lines
20. Mucin synthesis. UDP‐GlcNAc:GalNAc‐R β3‐N‐acetylglu‐cosaminyltransferase and UDP‐GlcNAc:GlcNAcβ1–3 GalNAc‐R (GlcNAc to GalNAc) β6‐N‐acetylglucosaminyltransferase from pig and rat colon mucosa
21. Synthetic mucin fragments. Benzyl 2‐acetamido‐6‐O‐(2‐acetamido‐2‐deoxy‐β‐D‐glucopyranosyl)‐2‐deoxy‐3‐O‐β‐D‐galactopyranosyl‐α‐D‐galactopyranoside and benzyl 2‐acetamido‐6‐O‐(2‐acetamido‐2‐deoxy‐β‐D‐glucopyranosyl)‐3‐O‐6‐O‐(2‐acetamido‐2‐deoxy‐β‐D‐glucopyranosyl)‐β‐D‐galactopyranosyl‐2‐deoxy‐α‐D‐galactopyranoside
22. Synthetic mucin fragments. Benzyl 2‐(2‐acetamido‐2‐deoxy‐α‐D‐glucopyranosyl)‐(1‐3)‐O‐β‐D‐galactopyranosyl‐(1‐3)‐O‐[(2‐acetamido‐2‐deoxy‐β‐D‐glucopyranosyl)‐(1‐6)‐2‐acetamido‐2‐deoxy‐α‐D‐galactopyranoside and benzyl O‐(2‐acetamido‐2‐deoxy‐β‐D‐glucopyranosyl)‐(1‐3)‐O‐β‐D‐galactopyranosyl‐(1‐3)‐O‐β‐D‐galactopyranosyl‐(1‐6)]2‐acetamido‐2‐deoxy‐α‐D‐galactopyranoside
23. Synthesis of benzyl 2‐acetamido‐3‐O‐ and 6‐O‐(2‐acetamido‐2‐deoxy‐β‐D‐glucopyranosyl)‐2‐deoxy‐α‐D‐galactopyranoside
24. Synthesis of 2‐acetamido‐4‐O‐[3‐O‐(2‐acetamido‐2‐deoxy‐β‐D‐glucopyranosyl)‐β‐D‐galactopyranosyl]‐2‐deoxy‐D‐glucopyranose and two related trisaccharides containing the “Lacto‐N‐Biose II” unit
25. Synthesis of benzyl O‐(2‐O‐Me‐β‐D‐galactopyranosyl)‐(1‐3)‐acetamido‐2‐deoxy‐β‐D‐glucopyranoside [benzyl 2′‐O‐methyllacto‐N‐bioside I], and its higher saccharide containing an O‐(2‐O‐Me‐β‐D‐galactopyranosyl)‐(1‐3)‐2‐acetamido‐2‐deoxy‐β‐D‐glucopyranosyl group as a potential substrate for (1‐4)‐α‐L‐fucosyltransferase
26. Synthesis of 2′‐O‐substituted β‐D‐Gal‐(1‐4)‐β‐D‐GlcNAc‐1‐O‐Bn as specific acceptor for α‐L‐(1‐3)‐fucosyltransferases
27. Biosynthesis of O‐glycans in leukocytes from normal donors and from patients with leukemia: increase in O‐glycan core 2 UDP‐GlcNAc:Galβ3Gal‐NAcα‐R (GlcNAc to GalNAc) β(1‐6)‐N‐acetylglucosami‐nyltransferase in leukemic cells
28. Molecular cloning of human intestinal mucin cDNAs
29. The isolation and characteristics of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients
30. Secreted mucus glycoproteins in cell and organ culture
31. Characterization of the major and minor mucus glycoproteins from bovine submandibular gland
32. The roles of enteric bacterial sialidase, sialate O‐acetyl esterase and glycosulfatase in the degradation of human colonic mucin
33. The biosynthesis of serine (threonine)‐N‐acetylgalactosamine‐linked carbohydrate moieties
34. The evolution of cancer of the colon and rectum
35. Biological consequences of the genetic changes which occur during human colorectal carcinogenesis
36. O‐glycan biosynthesis in human cancer cells
37. Regulation of O‐glycan biosynthesis in human colon cancer
38. Processing O‐glycan core 1, Galβ1‐3GalNAcβ‐R. Specificities of core 2 UDP‐GlcNAc:Galβ1‐3GalNAc‐R β6‐N‐acetylglucosaminyltransferase and CMP‐sialic acid:Galβ1‐3GalNAc‐R α3‐sialyltransferase
39. Mucin biosynthesis: purification and characterization of a mucin β6‐N‐acetylglucosaminyltransferase
40. Molecular cloning of cDNA encoding UDP‐GlcNAc:Galβ1‐3GalNAc‐R (GlcNAc to GalNAc) β1‐6 N‐acetylglucosaminyltransferase, an O‐glycan branching enzyme, by gene transfer into CHO cells expressing polyoma large T‐antigen
41. b blood group antigens in human colon by α‐2‐L‐fucosylation
42. Detection of a mucin marker for the adenoma‐carcinoma sequence in human colonic mucosa by monoclonal antibody AM‐3
43. Tumorigenicity, mucin production and the AM‐3 epitope expression in clones selected from th HT‐29 colon carcinoma cell line
44. Differential production of high molecular mass sulfated glycoproteins in normal colonic mucosa, primary colon carcinoma, and metastases
45. Monoclonal antibodies to human colorectal epithelium: markers for differentiation and tumour characterization
46. Distribution of O‐acetylated sialomucin in the normal and diseased human gastrointestinal tract assessed using a newly characterized monoclonal antibody
47. Human colonic sulfomucin identified by a specific monoclonal antibody
48. Immunochemical studies on the differential binding properties of two monoclonal antibodies reacting with Tn red cells
49. Immunoglobulin G3 monoclonal antibody directed to Tn antigen (tumor‐associated α‐N‐acetylgalactosaminyl epitope) that does not cross‐react with blood group A antigen
50. Preparation and characterization of monoclonal antibodies directed to the tumor associated O‐linked sialosyl‐2‐6 α‐N‐acetylgalactosaminyl (sialosyl‐Tn) epitope
51. A monoclonal antibody that recognises a cluster of a disaccharide, NeuAcα2‐6GalNAc, in mucin‐type glycoproteins
52. x
53. x as a new tumor‐associated antigen
54. Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of human milk mucin